{"id":12930,"date":"2025-10-02T08:00:00","date_gmt":"2025-10-02T12:00:00","guid":{"rendered":"https:\/\/vaccines.phila.gov\/?p=12930"},"modified":"2025-09-30T14:17:29","modified_gmt":"2025-09-30T18:17:29","slug":"penmenvy-meningococcal-groups-a-b-c-w-and-y-now-available-through-vfc","status":"publish","type":"post","link":"https:\/\/vaccines.phila.gov\/index.php\/penmenvy-meningococcal-groups-a-b-c-w-and-y-now-available-through-vfc\/","title":{"rendered":"Penmenvy (Meningococcal Groups A, B, C, W, and Y) Now Available Through VFC"},"content":{"rendered":"\n

On February 14, 2025,\u00a0the Food and Drug Administration (FDA) approved GSK\u2019s MenABCWY vaccine<\/strong><\/u><\/a>, Penmenvy, for use in individuals aged 10 through 25 years.<\/p>\n\n\n\n

Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) is now available through the Vaccines for Children (VFC) program. The vaccine is supplied as a box of 10-dose kits, with single-dose vials and pre-filled syringes for reconstitution. Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) is a combination vaccine with 2 active components: Menveo (meningococcal groups A, C, W, and Y vaccine) and Bexsero (meningococcal group B vaccine).<\/p>\n\n\n\n

To add this formulation to your office’s list of vaccines, use the button below to complete a change request form.<\/p>\n\n\n\n

<\/p>\n\n\n\n

\n
Change Request Form<\/a><\/div>\n<\/div>\n\n\n\n


Our team will review your request and reply with next steps. We recommend that providers that are affiliated or part of a system use the same vaccine presentations across sites to ensure standardization and help prevent administration errors.\u00a0<\/p>\n\n\n\n

Penmenvy may be administered in place of separate MCV4 (quadrivalent meningococcal conjugate vaccine) and MenB (meningococcal B vaccine) vaccines when both are indicated. As a reminder, MenB vaccines are not interchangeable.* <\/p>\n\n\n\n

The same vaccine (either Bexsero by GSK or Trumenba by Pfizer) must be used for all doses in the MenB series, including booster doses. If a patient begins the series with Penmenvy, they must complete it with Bexsero (MenB-4C, GSK). Penmenvy cannot be used in combination with Trumenba (MenB-FHbp, Pfizer). <\/p>\n\n\n\n

*The MenACWY components (i.e., Menveo and MenQuadfi) are interchangeable.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Indications<\/strong><\/p>\n\n\n\n